Form 8-K

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

FORM 8-K

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

Date of report (Date of earliest event reported): October 29, 2015

 

 

PFIZER INC.

(Exact name of registrant as specified in its charter)

 

 

 

Delaware    1-3619    13-5315170
(State or other    (Commission File    (I.R.S. Employer
jurisdiction of    (Number)    Identification No.)
incorporation)      

 

235 East 42nd Street, New York, New York    10017
(Address of principal executive offices)    (Zip Code)

Registrant’s telephone number, including area code: (212) 733-2323

Not Applicable

(Former Name or Former Address, if changed since last report)

 

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2 (b))

 

¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 

 


Item 7.01 Regulation FD Disclosure

On October 29, 2015, Pfizer Inc. (the “Company”) issued an announcement, a copy of which is attached as Exhibit 99.1 hereto and is incorporated by reference in its entirety into this Item 7.01.

Pursuant to General Instruction B.2. to Form 8-K, the information set forth in this Item 7.01 shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section.

Item 9.01 Financial Statements and Exhibits

(d) Exhibits

 

Exhibit 99.1 –   Announcement of the Company, dated October 29, 2015.


SIGNATURE

Under the requirements of the Securities Exchange Act of 1934, the registrant has caused this report to be signed on its behalf by the authorized undersigned.

 

PFIZER INC.
By:   /s/ Margaret M. Madden
 

 

  Margaret M. Madden
 

Vice President and Corporate Secretary

Chief Governance Counsel

Dated: October 29, 2015


EXHIBIT INDEX

 

Exhibit No.

  

Description

Exhibit 99.1    Announcement of the Company, dated October 29, 2015.